Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
11 | 49182310 | intron variant | C/A | snv | 4.2E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
11 | 49146109 | 3 prime UTR variant | T/C | snv | 1.4E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
11 | 49203333 | intron variant | G/A | snv | 7.8E-03 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.851 | 0.160 | 11 | 49206068 | stop lost | A/G | snv | 0.28 | 0.33 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.160 | 11 | 49206068 | stop lost | A/G | snv | 0.28 | 0.33 |
|
0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.724 | 0.400 | 11 | 49185773 | missense variant | G/A | snv | 4.1E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.030 | 1.000 | 3 | 2003 | 2010 | |||||||
|
0.763 | 0.280 | 11 | 49156734 | missense variant | G/A | snv | 4.0E-05 | 2.1E-05 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2009 | 2015 | ||||||
|
0.763 | 0.280 | 11 | 49154384 | stop gained | G/A | snv | 1.2E-05 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2009 | 2015 | |||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases | 0.020 | 1.000 | 2 | 2004 | 2010 | ||||||||
|
0.724 | 0.400 | 11 | 49185773 | missense variant | G/A | snv | 4.1E-06 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||||
|
0.763 | 0.280 | 11 | 49156734 | missense variant | G/A | snv | 4.0E-05 | 2.1E-05 |
|
0.020 | 0.500 | 2 | 2008 | 2015 | |||||||
|
0.763 | 0.280 | 11 | 49156734 | missense variant | G/A | snv | 4.0E-05 | 2.1E-05 |
|
Digestive System Diseases; Neoplasms | 0.020 | 0.500 | 2 | 2008 | 2015 | ||||||
|
0.763 | 0.280 | 11 | 49154384 | stop gained | G/A | snv | 1.2E-05 |
|
0.020 | 0.500 | 2 | 2008 | 2015 | ||||||||
|
0.763 | 0.280 | 11 | 49154384 | stop gained | G/A | snv | 1.2E-05 |
|
Digestive System Diseases; Neoplasms | 0.020 | 0.500 | 2 | 2008 | 2015 | |||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Nervous System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Skin and Connective Tissue Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.790 | 0.320 | 11 | 49206785 | missense variant | C/G;T | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.851 | 0.120 | 11 | 49146838 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.120 | 11 | 49146838 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.120 | 11 | 49146838 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 |